The approved age range for HUMIRA in the U.S.and in Australia is 4 years of age and older, and recent approval in EU for JIA patients 2 to < 4 years of age.
Patients who discontinue from the registry before 10 years will be offered to participate in the direct to Health Care Provider follow-up process, as allowed by local regulations.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00783510?cond=%22Arthritis%22&lup_s=08/23/2013&lup_d=30
